volume 37 issue 48 pages 16846-16852

Crystal Structure of Neurotrophin-3 Homodimer Shows Distinct Regions Are Used To Bind Its Receptors,

Publication typeJournal Article
Publication date1998-11-12
scimago Q1
wos Q3
SJR1.175
CiteScore5.3
Impact factor3.0
ISSN00062960, 15204995, 1943295X
PubMed ID:  9836577
Biochemistry
Abstract
Neurotrophin-3 (NT-3) is a cystine knot growth factor that promotes the survival, proliferation, and differentiation of developing neurons and is a potential therapeutic for neurodegenerative diseases. To clarify the structural basis of receptor specificity and the role of neurotrophin dimerization in receptor activation, the structure of the NT-3 homodimer was determined using X-ray crystallography. The orthorhombic crystals diffract to 2.4 A, with dimer symmetry occurring about a crystallographic 2-fold axis. The overall structure of NT-3 resembles that of the other neurotrophins, NGF and BDNF; each protomer forms a twisted four-stranded beta sheet, with three intertwined disulfide bonds. There are notable differences, however, between NT-3 and NGF in the surface loops and in three functionally important regions, shown in previous mutagenesis studies to be critical for binding. One such difference implies that NT-3's binding affinity and specificity depend on a novel hydrogen bond between Gln 83, a residue important for binding specificity with TrkC, and Arg 103, a residue crucial for binding affinity with TrkC. NT-3's extensive dimer interface buries much of the otherwise solvent-accessible hydrophobic surface area and suggests that the dimeric state is stabilized through the formation of this hydrophobic core. A comparison of the dimer interface between the NT-3 homodimer and the BDNF/NT-3 heterodimer reveals similar patterns of hydrogen bonds and nonpolar contacts, which reinforces the notion that the evolutionarily conserved neurotrophin interface resulted from the need for receptor dimerization in signal initiation.
Found 
Found 

Top-30

Journals

1
2
Journal of Biological Chemistry
2 publications, 4%
Protein Science
2 publications, 4%
Russian Journal of Bioorganic Chemistry
2 publications, 4%
Annual Review of Neuroscience
2 publications, 4%
Journal of Medicinal Chemistry
1 publication, 2%
Philosophical Transactions of the Royal Society B: Biological Sciences
1 publication, 2%
Structure
1 publication, 2%
Journal of Controlled Release
1 publication, 2%
Cell
1 publication, 2%
Neuroscientist
1 publication, 2%
Biosensors
1 publication, 2%
Frontiers in Molecular Biosciences
1 publication, 2%
Nature
1 publication, 2%
Molecular Neurobiology
1 publication, 2%
Endocrine
1 publication, 2%
Neurological Sciences
1 publication, 2%
Neurochemistry International
1 publication, 2%
Biomaterials
1 publication, 2%
Biochimica et Biophysica Acta - Reviews on Cancer
1 publication, 2%
Pathology Research and Practice
1 publication, 2%
Computational and Structural Biotechnology Journal
1 publication, 2%
Pharmacology and Therapeutics
1 publication, 2%
International Journal of Developmental Neuroscience
1 publication, 2%
Journal of Peptide Science
1 publication, 2%
FEBS Letters
1 publication, 2%
Annals of the New York Academy of Sciences
1 publication, 2%
FASEB Journal
1 publication, 2%
Langmuir
1 publication, 2%
Expert Review of Respiratory Medicine
1 publication, 2%
1
2

Publishers

2
4
6
8
10
12
Elsevier
11 publications, 22%
Wiley
7 publications, 14%
Springer Nature
5 publications, 10%
MDPI
4 publications, 8%
Annual Reviews
3 publications, 6%
American Chemical Society (ACS)
2 publications, 4%
American Society for Biochemistry and Molecular Biology
2 publications, 4%
Pleiades Publishing
2 publications, 4%
Taylor & Francis
2 publications, 4%
The Royal Society
1 publication, 2%
SAGE
1 publication, 2%
Frontiers Media S.A.
1 publication, 2%
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 2%
Walter de Gruyter
1 publication, 2%
American Society for Microbiology
1 publication, 2%
American Physiological Society
1 publication, 2%
Society for Neuroscience
1 publication, 2%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 2%
2
4
6
8
10
12
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
50
Share
Cite this
GOST |
Cite this
GOST Copy
Butte M. et al. Crystal Structure of Neurotrophin-3 Homodimer Shows Distinct Regions Are Used To Bind Its Receptors, // Biochemistry. 1998. Vol. 37. No. 48. pp. 16846-16852.
GOST all authors (up to 50) Copy
Butte M., Hwang P. K., MOBLEY W. P., FLETTERICK R. J. Crystal Structure of Neurotrophin-3 Homodimer Shows Distinct Regions Are Used To Bind Its Receptors, // Biochemistry. 1998. Vol. 37. No. 48. pp. 16846-16852.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/bi981254o
UR - https://doi.org/10.1021/bi981254o
TI - Crystal Structure of Neurotrophin-3 Homodimer Shows Distinct Regions Are Used To Bind Its Receptors,
T2 - Biochemistry
AU - Butte, M.
AU - Hwang, Peter K.
AU - MOBLEY, WILLIAM P.
AU - FLETTERICK, ROBERT J.
PY - 1998
DA - 1998/11/12
PB - American Chemical Society (ACS)
SP - 16846-16852
IS - 48
VL - 37
PMID - 9836577
SN - 0006-2960
SN - 1520-4995
SN - 1943-295X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1998_Butte,
author = {M. Butte and Peter K. Hwang and WILLIAM P. MOBLEY and ROBERT J. FLETTERICK},
title = {Crystal Structure of Neurotrophin-3 Homodimer Shows Distinct Regions Are Used To Bind Its Receptors,},
journal = {Biochemistry},
year = {1998},
volume = {37},
publisher = {American Chemical Society (ACS)},
month = {nov},
url = {https://doi.org/10.1021/bi981254o},
number = {48},
pages = {16846--16852},
doi = {10.1021/bi981254o}
}
MLA
Cite this
MLA Copy
Butte, M., et al. “Crystal Structure of Neurotrophin-3 Homodimer Shows Distinct Regions Are Used To Bind Its Receptors,.” Biochemistry, vol. 37, no. 48, Nov. 1998, pp. 16846-16852. https://doi.org/10.1021/bi981254o.